OTA has been classified as a possible human carcinogen (Group 2B) by the International Agency for Research on Cancer (IARC). This classification is based on evidence from animal studies showing that OTA can cause kidney tumors. Although direct evidence in humans is limited, the potential carcinogenic effects of OTA have raised significant concerns, particularly regarding its role in renal cell carcinoma.
